BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26427551)

  • 1. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    Guillot PV
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).
    Spinelli V; Guillot PV; De Coppi P
    Organogenesis; 2013; 9(2):101-10. PubMed ID: 23823661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage.
    Medvedev SP; Grigor'eva EV; Shevchenko AI; Malakhova AA; Dementyeva EV; Shilov AA; Pokushalov EA; Zaidman AM; Aleksandrova MA; Plotnikov EY; Sukhikh GT; Zakian SM
    Stem Cells Dev; 2011 Jun; 20(6):1099-112. PubMed ID: 20846027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
    Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
    Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.
    Velasquez-Mao AJ; Tsao CJM; Monroe MN; Legras X; Bissig-Choisat B; Bissig KD; Ruano R; Jacot JG
    PLoS One; 2017; 12(5):e0177824. PubMed ID: 28545044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions.
    Slamecka J; Laurini J; Shirley T; Hoerstrup SP; Weber B; Owen L; McClellan S
    J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases.
    Antonucci I; Provenzano M; Rodrigues M; Pantalone A; Salini V; Ballerini P; Borlongan CV; Stuppia L
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.
    Hawkins KE; Corcelli M; Dowding K; Ranzoni AM; Vlahova F; Hau KL; Hunjan A; Peebles D; Gressens P; Hagberg H; de Coppi P; Hristova M; Guillot PV
    Stem Cells Transl Med; 2018 May; 7(5):439-449. PubMed ID: 29489062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.
    Galende E; Karakikes I; Edelmann L; Desnick RJ; Kerenyi T; Khoueiry G; Lafferty J; McGinn JT; Brodman M; Fuster V; Hajjar RJ; Polgar K
    Cell Reprogram; 2010 Apr; 12(2):117-25. PubMed ID: 20677926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system.
    Lu HE; Tsai MS; Yang YC; Yuan CC; Wang TH; Lin XZ; Tseng CP; Hwang SM
    Exp Cell Res; 2011 Aug; 317(13):1895-903. PubMed ID: 21640101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.
    Yan JM; Li DZ
    Hemoglobin; 2017 May; 41(3):198-202. PubMed ID: 28835139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A plethora of human pluripotent stem cells.
    Gao L; Thilakavathy K; Nordin N
    Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System.
    Bertin E; Piccoli M; Franzin C; Nagy A; Mileikovsky M; De Coppi P; Pozzobon M
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.